Drug–drug interactions with statins: will pitavastatin overcome the statins’ Achilles’ heel?

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

(2010) Michael S. Kostapanos et al.   American Journal of Cardiovascular Drugs

Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction

(2010) Kristian M. Bailey et al.   Circulation-Cardiovascular Genetics

Pitavastatin: a distinctive lipid-lowering drug

(2010) Leiv Ose   Clinical Lipidology

New evidence on pitavastatin: efficacy and safety in clinical studies

(2010) Tamio Teramoto et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Abstract: P770 ROBUST EFFICACY OF PITAVASTATIN AND COMPARABLE SAFETY TO PRAVASTATIN

(2009) S Stender et al.   ATHEROSCLEROSIS SUPPLEMENTS

Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia

(2009) Dragos Budinski et al.   Clinical Lipidology

Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia

(2009) Leiv Ose et al.   CURRENT MEDICAL RESEARCH AND OPINION

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

(2009) Ichiro Ieiri et al.   Expert Opinion on Drug Metabolism & Toxicology

Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome

(2009) Takafumi Hiro et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

(2009) S P R Romaine et al.   PHARMACOGENOMICS JOURNAL

Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria

(2009) Jochen Schuler et al.   WIENER KLINISCHE WOCHENSCHRIFT

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

(2008) Eileen E. Ming et al.   Journal of Clinical Lipidology

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Drug–drug interaction with statins

(2008) Alberto Corsini et al.   Expert Review of Clinical Pharmacology